Explore Below
0 Dr. Garvit Chikara

Dr. Garvit Chikara

Senior Consultant - Breast Oncology

Nanavati Max Super Speciality Hospital, Mumbai, India
Speaks English, Hindi, Punjabi
  • Surgical Oncologist
  • 5
  • 126 Reviews
  • (Google)
  • 15+ years of exp.
  • 20k+ Consultations
  • 4k+ Surgeries

About Doctor

Dr. Garvit Chikara is a highly esteemed Breast Surgical Oncologist with over 17 years of extensive clinical and academic experience in the field of breast surgery. He currently holds the position of Associate Director of Breast Surgical Oncology at Nanavati Max Super Speciality Hospital, Mumbai, one of India’s leading centers for advanced cancer care. Dr. Chikara is recognized for his holistic approach to managing a wide spectrum of breast diseases, including both malignant conditions such as breast cancer and benign disorders like fibroadenomas, breast cysts, and gynecomastia. His clinical philosophy combines evidence-based surgical techniques with an emphasis on aesthetic preservation and psychological well-being, especially through oncoplastic breast surgery — a field that merges oncologic safety with cosmetic outcomes.

With a strong academic background and previous teaching tenure at Tata Memorial Hospital, one of Asia’s premier cancer institutions, Dr. Chikara is also deeply involved in research and surgical innovation. His compassionate patient care, coupled with a precision-driven surgical approach, has earned him respect among peers and patients alike, making him a sought-after expert in breast cancer treatment across India.

Schedule Your Consultation Today
Get expert care from one of India's leading Surgical Oncologist
Priority consultation · No waiting

Qualification & Education

  • MBBS
  • DNB (General Surgery)
  • HBNI Fellowship in Surgical Oncology

Conditions Treated

  • Breast Cancer
  • Ductal Carcinoma In Situ (DCIS)
  • Fibroadenoma
  • Breast Cysts
  • Gynecomastia
  • Phyllodes Tumor
  • Breast Abscess
  • Benign Breast Lumps
  • High-Risk Breast Lesions (e.g., atypical hyperplasia)
  • Recurrent Breast Tumors
Need Treatment for a Specific Condition?
Discuss your health concerns with Dr. Garvit Chikara

Procedure Performed

  • Breast-Conserving Surgery (Lumpectomy)
  • Modified Radical Mastectomy
  • Oncoplastic Breast Surgery
  • Sentinel Lymph Node Biopsy
  • Axillary Lymph Node Dissection
  • Vacuum-Assisted Breast Biopsy
  • Reconstructive Breast Surgery
Looking for a Specific Surgical Oncology Procedure?
Explore Treatment Options

Professional Memberships

  • Association of Breast Surgeons of India (ABSI)
  • Association of Surgeons of India (ASI)
  • European Society of Surgical Oncology (ESSO)
  • European Breast Cancer Research Association of Surgical Trialists (EUBREAST)

Awards & Recoginition

  • Certificate of Achievement in HMX Fundamentals-Genetics from Harvard Medical School
  • Iconic Healthcare Leadership Award by the Golden Aim Conference and Awards

FAQs

Dr. Garvit Chitkara specializes in Breast Surgical Oncology, focusing on the diagnosis, treatment, and surgical management of both benign and malignant breast conditions.

He treats -  Breast cancer (early and advanced stages), Fibroadenoma, cysts, gynecomastia Ductal Carcinoma In Situ (DCIS),  Breast abscess, nipple discharge, phyllodes tumor, Recurrent breast tumors and high-risk lesions.

Oncoplastic surgery combines cancer surgery with plastic surgery techniques to remove the tumor while preserving or restoring the natural appearance of the breast.

Yes, he provides second opinions, especially for complex breast cancer cases or for patients seeking alternatives to mastectomy.

Yes, he treats male breast conditions including gynecomastia and male breast cancer.

You can book an appointment directly through Nanavati Max Super Speciality Hospital or contact HOSPIDIO for assistance at [email protected] or via Call/WhatsApp: +91-9870538337.

Ready to Begin Your Journey to Better Health?
Connect with Dr. Garvit Chikara today for a personalized treatment plan.

Tell Us About Your Need

Free case review. Confidential. No obligation.